2021
DOI: 10.1016/j.kint.2021.07.024
|View full text |Cite
|
Sign up to set email alerts
|

A randomized multicenter trial on a lung ultrasound–guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
51
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 51 publications
(54 citation statements)
references
References 16 publications
0
51
0
Order By: Relevance
“…Volume status was assessed by measurement of IVCD and calculation of US-B lines score through lung ultrasound; the first has been validated for estimation of intravascular volume against the objective standard method of cardiac catheterization in ESKD [43], while the second is a novel, non-invasive, validated method for assessing extravascular lung water content [44]. Moreover, according to the latest KDIGO conclusions of Controversies Conference on BP and volume management, lung ultrasound guided dry-weight probing strategies are considered promising, given favorable effects on BP levels, echocardiographic parameters, and, more recently, on reducing recurrent decompensated heart failure episodes [8,[45][46][47]. We followed a careful design, including blinded matching for a set of crucial parameters; this resulted in the absence of differences between the two dialysis groups for the majority of important variables, including age, sex, dialysis vintage, and co-morbidities.…”
Section: Discussionmentioning
confidence: 99%
“…Volume status was assessed by measurement of IVCD and calculation of US-B lines score through lung ultrasound; the first has been validated for estimation of intravascular volume against the objective standard method of cardiac catheterization in ESKD [43], while the second is a novel, non-invasive, validated method for assessing extravascular lung water content [44]. Moreover, according to the latest KDIGO conclusions of Controversies Conference on BP and volume management, lung ultrasound guided dry-weight probing strategies are considered promising, given favorable effects on BP levels, echocardiographic parameters, and, more recently, on reducing recurrent decompensated heart failure episodes [8,[45][46][47]. We followed a careful design, including blinded matching for a set of crucial parameters; this resulted in the absence of differences between the two dialysis groups for the majority of important variables, including age, sex, dialysis vintage, and co-morbidities.…”
Section: Discussionmentioning
confidence: 99%
“…2). The one most commonly employed is the 28-site zone [31], used in the two aforementioned validation studies of Agricola et al [23] and Enghard et al [25], as well as in most observational studies and randomized clinical trials in patients with renal diseases [10,24,[32][33][34][35][36][37], including pediatric populations Fig. 2.…”
Section: Lung Scanning Protocolsmentioning
confidence: 99%
“…The LUST study was an international, multicenter randomized controlled trial where the effect of a lung USguided treatment strategy on major outcomes (all-cause death, nonfatal myocardial infarction, and decompensated HF) was compared to standard-of-care in high-risk HD patients (history of myocardial infarction or unstable angina, acute coronary syndrome, or stable angina pectoris with documented coronary artery disease or HF with NYHA class III-IV) [37]. After a median follow-up of 1.49 years and randomization of 367 patients, no difference between the active and control arm was seen for the primary composite endpoint (all-cause death, nonfatal myocardial infarction, or decompensated HF) (HR 0.88, 95% CI: 0.63-1.24) or the secondary outcome of cardiovascular hospitalization (HR: 1.02, 95% CI: 0.71-1.46).…”
Section: Interventional Studies Using Lung Ultrasound For Assessment ...mentioning
confidence: 99%
“…The total number of USBLs from all 28 sites gave a score that represents the severity of pulmonary congestion. Lung ultrasound tests were performed by the same experienced nephrologist who has received formal training via a remote web-based program and has been certified by an expert [8,[19][20][21]. The number of USBLs was compared in subgroups in relation to AVF patency (AVF−, AVF+, Qa < 1500 mL/min, Qa > 1500 mL/min), presence of symptoms, and history of heart disease.…”
Section: Ultrasound Assessmentmentioning
confidence: 99%
“…In a recent multicenter trial, lung ultrasound-guided hemodialysis treatment was compared with regular care. In the active arm, recurrent episodes of decompensated heart failure and cardiovascular events were reduced [8]. Lung ultrasound also has great potential as a screening and monitoring tool in SARS-CoV-2 infection.…”
Section: Introductionmentioning
confidence: 99%